Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | -5.69% | -3.33% | -34.83% |
May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.83% | 90.18M | |
+53.89% | 63.85B | |
-1.87% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.36% | 26.52B | |
-21.43% | 18.69B | |
+2.67% | 12.73B | |
+22.31% | 12.11B | |
+27.48% | 12.07B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Protalix BioTherapeutics : HC Wainwright Adjusts Price Target on Protalix BioTherapeutics to $7 From $11, Maintains Buy Rating